BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 34982553)

  • 1. Size-Reduced Macrocyclic Analogues of [Pyr
    Tran K; Sainsily X; Côté J; Coquerel D; Couvineau P; Saibi S; Haroune L; Besserer-Offroy É; Flynn-Robitaille J; Resua Rojas M; Murza A; Longpré JM; Auger-Messier M; Lesur O; Bouvier M; Marsault É; Boudreault PL; Sarret P
    J Med Chem; 2022 Jan; 65(1):531-551. PubMed ID: 34982553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constraining the Side Chain of C-Terminal Amino Acids in Apelin-13 Greatly Increases Affinity, Modulates Signaling, and Improves the Pharmacokinetic Profile.
    Trân K; Van Den Hauwe R; Sainsily X; Couvineau P; Côté J; Simard L; Echevarria M; Murza A; Serre A; Théroux L; Saibi S; Haroune L; Longpré JM; Lesur O; Auger-Messier M; Spino C; Bouvier M; Sarret P; Ballet S; Marsault É
    J Med Chem; 2021 May; 64(9):5345-5364. PubMed ID: 33524256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signaling Modulation via Minimal C-Terminal Modifications of Apelin-13.
    Théroux L; Van Den Hauwe R; Trân K; Fournier J; Desgagné M; Meneboo N; Lavallée A; Fröhlich U; Côté J; Hollanders C; Longpré JM; Murza A; Marsault E; Sarret P; Boudreault PL; Ballet S
    ACS Pharmacol Transl Sci; 2023 Feb; 6(2):290-305. PubMed ID: 36798478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vitro and In Vivo Evaluation of a Small-Molecule APJ (Apelin Receptor) Agonist, BMS-986224, as a Potential Treatment for Heart Failure.
    Gargalovic P; Wong P; Onorato J; Finlay H; Wang T; Yan M; Crain E; St-Onge S; Héroux M; Bouvier M; Xu C; Chen XQ; Generaux C; Lawrence M; Wexler R; Gordon D
    Circ Heart Fail; 2021 Mar; 14(3):e007351. PubMed ID: 33663236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationship of novel macrocyclic biased apelin receptor agonists.
    Murza A; Sainsily X; Côté J; Bruneau-Cossette L; Besserer-Offroy É; Longpré JM; Leduc R; Dumaine R; Lesur O; Auger-Messier M; Sarret P; Marsault É
    Org Biomol Chem; 2017 Jan; 15(2):449-458. PubMed ID: 27924341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-Activity Relationship and Bioactivity of Short Analogues of ELABELA as Agonists of the Apelin Receptor.
    Trân K; Murza A; Sainsily X; Delile E; Couvineau P; Côté J; Coquerel D; Peloquin M; Auger-Messier M; Bouvier M; Lesur O; Sarret P; Marsault É
    J Med Chem; 2021 Jan; 64(1):602-615. PubMed ID: 33350824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hypotensive effect of activated apelin receptor is correlated with β-arrestin recruitment.
    Besserer-Offroy É; Bérubé P; Côté J; Murza A; Longpré JM; Dumaine R; Lesur O; Auger-Messier M; Leduc R; Marsault É; Sarret P
    Pharmacol Res; 2018 May; 131():7-16. PubMed ID: 29530600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac action of the first G protein biased small molecule apelin agonist.
    Read C; Fitzpatrick CM; Yang P; Kuc RE; Maguire JJ; Glen RC; Foster RE; Davenport AP
    Biochem Pharmacol; 2016 Sep; 116():63-72. PubMed ID: 27475715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, characterization, and first-in-human study of the vascular actions of a novel biased apelin receptor agonist.
    Brame AL; Maguire JJ; Yang P; Dyson A; Torella R; Cheriyan J; Singer M; Glen RC; Wilkinson IB; Davenport AP
    Hypertension; 2015 Apr; 65(4):834-40. PubMed ID: 25712721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential association modes of the thrombin receptor PAR1 with Galphai1, Galpha12, and beta-arrestin 1.
    Ayoub MA; Trinquet E; Pfleger KD; Pin JP
    FASEB J; 2010 Sep; 24(9):3522-35. PubMed ID: 20410441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of 6-hydroxy-5-phenyl sulfonylpyrimidin-4(1H)-one APJ receptor agonists.
    Tora G; Jiang J; Bostwick JS; Gargalovic PS; Onorato JM; Luk CE; Generaux C; Xu C; Galella MA; Wang T; He Y; Wexler RR; Finlay HJ
    Bioorg Med Chem Lett; 2021 Oct; 50():128325. PubMed ID: 34403724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apelin-APJ signaling is a critical regulator of endothelial MEF2 activation in cardiovascular development.
    Kang Y; Kim J; Anderson JP; Wu J; Gleim SR; Kundu RK; McLean DL; Kim JD; Park H; Jin SW; Hwa J; Quertermous T; Chun HJ
    Circ Res; 2013 Jun; 113(1):22-31. PubMed ID: 23603510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apelin-36-[L28A] and Apelin-36-[L28C(30kDa-PEG)] peptides that improve diet induced obesity are G protein biased ligands at the apelin receptor.
    Nyimanu D; Kuc RE; Williams TL; Bednarek M; Ambery P; Jermutus L; Maguire JJ; Davenport AP
    Peptides; 2019 Nov; 121():170139. PubMed ID: 31472173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of potent pyrazole based APELIN receptor (APJ) agonists.
    Narayanan S; Vasukuttan V; Rajagopal S; Maitra R; Runyon SP
    Bioorg Med Chem; 2020 Feb; 28(4):115237. PubMed ID: 31948845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of serine 348 on the apelin receptor as a novel regulatory phosphorylation site in apelin-13-induced G protein-independent biased signaling.
    Chen X; Bai B; Tian Y; Du H; Chen J
    J Biol Chem; 2014 Nov; 289(45):31173-87. PubMed ID: 25271156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of apelin on the cardiac hemodynamics in hypertensive rats with heart failure.
    Pang H; Han B; Yu T; Zong Z
    Int J Mol Med; 2014 Sep; 34(3):756-64. PubMed ID: 24993609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apelin and APJ orchestrate complex tissue-specific control of cardiomyocyte hypertrophy and contractility in the hypertrophy-heart failure transition.
    Parikh VN; Liu J; Shang C; Woods C; Chang AC; Zhao M; Charo DN; Grunwald Z; Huang Y; Seo K; Tsao PS; Bernstein D; Ruiz-Lozano P; Quertermous T; Ashley EA
    Am J Physiol Heart Circ Physiol; 2018 Aug; 315(2):H348-H356. PubMed ID: 29775410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardioprotective effect of apelin-13 on cardiac performance and remodeling in end-stage heart failure.
    Koguchi W; Kobayashi N; Takeshima H; Ishikawa M; Sugiyama F; Ishimitsu T
    Circ J; 2012; 76(1):137-44. PubMed ID: 22082814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GPCR structure and function relationship: identification of a biased apelin receptor mutant.
    Ban T; Li X; Ma X; Yang H; Song Y; Sun Y; Shen M; Li N; Zhang MY; Ma Y; Zhong W; Zhang M; Hu LA
    Biochem J; 2018 Dec; 475(23):3813-3826. PubMed ID: 30409826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individual phosphorylation sites at the C-terminus of the apelin receptor play different roles in signal transduction.
    Chen J; Chen X; Li S; Jiang Y; Mao H; Zhang R; Ji B; Yan M; Cai X; Wang C
    Redox Biol; 2020 Sep; 36():101629. PubMed ID: 32863206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.